title: Differential effects of the tricyclic antidepressant amoxapine on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters.
abstract: We examined the effects of nine different tricyclic antidepressant drugs on the glycine uptake mediated by the glycine transporter 1b (GLYT1b) and glycine transporter 2a (GLYT2a) stably expressed in human embryonic kidney 293 cells. Desipramine, imipramine, clomipramine, nomifensine and mianserin had no effect on the activity of the glycine transporters. Doxepin, amitriptyline and nortriptyline inhibited the two transporter subtypes to a similar extent. Amoxapine displayed a selective inhibition of GLYT2a behaving as a 10 fold more efficient inhibitor of this isoform than of GLYT1b. Kinetic analysis of the initial rates of glycine uptake by GLYT2a as a function of either glycine, chloride or sodium concentration, in the absence and presence of amoxapine indicated that amoxapine behaved as a competitive inhibitor of both glycine and chloride and a mixed-type inhibitor with respect to sodium. A kinetic model was developed which explains adequately these data, and gives information about the order of binding of sodium and chloride ions to GLYT2a. Our results may contribute to the development of the glycine transporter pharmacology. Additionally, the inhibition of the glycine uptake by GLYT2 is suggested to have some role in the sedative and psychomotor side effects of amoxapine. British Journal of Pharmacology (2000) 129, 200 - 206
authors.affiliation: Departamento de Biología Molecular.Centro de Biología Molecular 'Severo Ochoa'. Facultad de Ciencias, Universidad Autónoma de Madrid, 28049 Madrid, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Núñez
authors.forename: B
authors.initials: B
authors.lastname: López-Corcuera
authors.forename: J
authors.initials: J
authors.lastname: Vázquez
authors.forename: C
authors.initials: C
authors.lastname: Giménez
authors.forename: C
authors.initials: C
authors.lastname: Aragón
mesh_terms: D000465:Algorithms; D026921:Amino Acid Transport Systems, Neutral; D000657:Amoxapine / Q000494:pharmacology*; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D002352:Carrier Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002460:Cell Line; D002712:Chlorides / Q000378:metabolism; D005998:Glycine / Q000378:metabolism*; D050487:Glycine Plasma Membrane Transport Proteins; D006801:Humans; D007700:Kinetics; D011506:Proteins / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D012964:Sodium / Q000378:metabolism
chemical_list: D026921:Amino Acid Transport Systems, Neutral; D000929:Antidepressive Agents, Tricyclic; D002352:Carrier Proteins; D002712:Chlorides; D050487:Glycine Plasma Membrane Transport Proteins; D011506:Proteins; D011994:Recombinant Proteins; C493271:SLC6A5 protein, human; C493268:SLC6A9 protein, human; D012964:Sodium; D000657:Amoxapine; D005998:Glycine